Ozempic is one of the most widely prescribed medications in the United States with semaglutide as the active ingredient. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a natural hormone that helps regulate blood sugar levels, appetite, and digestion.
Ozempic was first approved in 2017 for the treatment of type 2 diabetes. It also received approval to treat chronic kidney disease in patients with type 2 diabetes in 2025. It has gained widespread attention for its effectiveness in supporting weight reduction although Ozempic is not FDA-approved specifically for weight loss. Clinical trials have shown that individuals using Ozempic lost an average of 8 to 10 pounds while also experiencing a reduced risk of heart attack and other cardiovascular events. About 25% of Ozempic prescriptions are written for people without diabetes currently.
It is not surprising that Ozempic prescriptions have increased by 857% since 2019 due to its effectiveness. The surge in demand combined with manufacturer supply shortages has made the medication more difficult to access. The out-of-pocket cost that is around $349 per month for self-pay patients may be unaffordable for many individuals if insurance does not cover Ozempic.
Many people are now exploring alternatives to Ozempic. The following guide reviews the GLP-1 medications currently available on the market including comparisons of cost, dosing, and how they differ from Ozempic to help simplify the search.
Key Takeaways
Ozempic is a GLP-1 medication approved for the treatment of type 2 diabetes and is prescribed off-label for weight loss. The rising demand and high costs of the drug have made Ozempic increasingly difficult to access.
Several other GLP-1 medications including Rybelsus, Mounjaro, Trulicity, Victoza, Bydureon BCise, and Byetta, are also approved for the treatment of type 2 diabetes.
Additional GLP-1 drugs such as Wegovy available as injection and pill forms, Saxenda, and Zepbound are specifically approved for weight management and weight loss.
Ozempic Alternatives for Type 2 Diabetes
Six additional GLP-1 medications have been approved for the treatment of type 2 diabetes as of 2026 including Rybelsus (semaglutide), Mounjaro (tirzepatide), Trulicity (dulaglutide), Victoza (liraglutide), Bydureon BCise (exenatide), and Byetta (exenatide).
Several of these medications may also help lower the risk of weight related health conditions similar to Ozempic including cardiovascular disease. You will find more information about each medication below along with a comparison chart outlining their costs, dosing schedules, and potential health benefits.
1. Rybelsus
Rybelsus is an oral medication used to help people with type 2 diabetes manage their blood glucose levels. It contains semaglutide which is the same active ingredient as Ozempic and Wegovy. It is taken as a tablet by mouth rather than a subcutaneous injection.
Rybelsus is taken once daily and is available in 3 mg, 7 mg, and 14 mg tablets. Participants in clinical trials taking the lowest dose lost an average of about 5 pounds over six months although it is not approved specifically for weight loss.
2. Mounjaro
Mounjaro belongs to a class of medications known as GLP-1 and GIP receptor agonists. It includes tirzepatide as the active ingredient. These drugs work similarly to GLP-1 medications like Ozempic but also mimic another gut hormone called glucose dependent insulinotropic polypeptide (GIP) which helps regulate blood sugar and appetite. Mounjaro is administered as a once-weekly injection.
Treatment typically begins with a 2.5 mg weekly injection which is usually increased to 5 mg after one month. Clinical trials have shown that patients taking the medication along with lifestyle changes lost about 20% of their body weight over one year although Mounjaro is FDA-approved for the treatment of type 2 diabetes.
3. Trulicity
Trulicity is an injectable GLP-1 receptor agonist that is used to improve blood sugar control in adults with type 2 diabetes. It may also help reduce the risk of stroke, heart attack, and other cardiovascular events.
It contains dulaglutide as the active ingredient which is different from the active ingredient of Ozempic although it works similarly to Ozempic. Treatment usually begins with 0.75 mg once weekly which may be increased to 1.5 mg, 3 mg, or 4.5 mg based on a recommendation from a healthcare provider. Patients in clinical trials taking the highest dose lost about 10 pounds over nine months suggesting potential weight related benefits while it is not approved for weight loss.
4. Victoza
This medication is another GLP-1 receptor agonist used to treat type 2 diabetes. Victoza contains liraglutide as the active ingredient and is taken daily unlike Ozempic which is administered once weekly. The dosing ranges from 0.6 mg to 1.8 mg per day depending on a healthcare provider’s recommendation.
5. Bydureon BCise
Bydureon BCise is an extended release injectable medication used to treat type 2 diabetes. Its active ingredient is exenatide which was the first GLP-1 medication approved by the FDA. Bydureon BCise is administered as a 2 mg injection once weekly.
6. Byetta
This is an injectable GLP-1 medication that contains exenatide which is the same active ingredient of Bydureon BCise. Byetta is injected twice daily before morning and evening meals unlike other GLP-1 medications that take once weekly or once daily to help manage blood sugar spikes.
Treatment typically begins with 5 mcg twice daily. A study performed with 200 participants showed those taking 5 mcg of Byetta lost an average of 6 pounds over six months while participants on a 10 mcg dose lost about 7 pounds.
| Brand Name | Drug Class | Dosage Form | Self-Pay Price | FDA-Approved For | Additional Health Benefits |
|---|---|---|---|---|---|
| Rybelsus (Semaglutide) | GLP-1 | Once daily oral tablet | $968/month | Type 2 diabetes | May support modest weight loss |
| Mounjaro (Tirzepatide) | GLP-1/ GIP | Weekly injection | $1, 070/month | Type 2 diabetes | May support modest weight loss |
| Trulicity (Dulaglutide) | GLP-1 | Weekly injection | $978/month | Type 2 diabetes | May aid weight loss, kidney function, and heart health |
| Victoza (Liraglutide) | GLP-1 | Daily injection | $815/month | Type 2 diabetes | May aid weight loss, kidney function, and heart health |
| Bydureon BCise (exenatide) | GLP-1 | Weekly injection | $977/month | Type 2 diabetes | May support modest weight loss |
| Byetta (exenatide) | GLP-1 | Twice daily injection | $1,006/month | Type 2 diabetes | May support modest weight loss |
Ozempic Alternatives for Weight Loss
There are four GLP-1 medications specifically approved for chronic weight management although Ozempic is not FDA-approved for weight loss. Those medications include Wegovy pen (semaglutide), Wegovy pill (semaglutide), Saxenda (liraglutide), and Zepbound (tirzepatide). Here is a comparison of how these weight loss medications measure up.
7. Wegovy pen
Wegovy injections contain semaglutide which is the same active ingredient as Ozempic but are formulated at a higher dose to enhance their effectiveness for weight loss. It is administered as a weekly injection pen like Ozempic. The standard dosage for Wegovy is 2.4 mg per week compared with Ozempic’s maximum dose of 2 mg per week.
8. Wegovy pill
Wegovy pill is the first FDA-approved oral GLP-1 medication for weight loss. It contains the same active ingredient as Ozempic but is taken as a daily oral tablet rather than a weekly injection.
These pills are available in four doses which are 1.5 mg, 4 mg, 9 mg, and 25 mg. Clinical studies have shown that patients with obesity or overweight, especially those with weight related health conditions, lost an average of about 14% of their body weight over one year.
9. Zepbound
Zepbound is a higher dose version of Mounjaro which is prescribed specifically for weight loss rather than type 2 diabetes. The active ingredient of this medication is tirzepatide. It may also help treat obstructive sleep apnea (OSA) in people with obesity. Zepbound is administered as a once weekly injection like Ozempic. But Zepbound acts on both GLP-1 and GIP receptors while Ozempic only targets GLP-1 receptors.
Treatment begins at 2.5 mg per week and may be increased based on individual response. Clinical trials have shown that patients taking the highest recommended dose of 15 mg per week lost an average of 48 pounds over 72 weeks.
10. Saxenda
This is a GLP-1 medication approved for weight loss. It contains the same active ingredient as the diabetes medication Victoza but is prescribed at a higher dose up to 3 mg per day compared with Victoza’s maximum of 1.8 mg per day. A clinical trial that took place for 56 weeks showed that patients taking Saxenda lost an average of 5 to 10% of their body weight.
| Brand Name | Drug Class | Dosage Form | List Price | FDA-Approved For | Additional Health Benefits |
|---|---|---|---|---|---|
| Wegovy pen (Semaglutide) | GLP-1 | Weekly injection | $199/month for first two months, then $349/month | Weight loss | May support heart health |
| Wegovy pill (Semaglutide) | GLP-1 | Once daily oral tablet | $149/month for lower doses (1.5 mg, 4 mg), $299/month for higher doses (9 mg, 25 mg) | Weight loss | May support heart health |
| Saxenda (Liraglutide) | GLP-1 | Daily injection | $1,349/month | Weight loss | N/A |
| Zepbound (Tirzepatide) | GLP-1/ GIP | Weekly injection | $1,060/month, or as low as $299/month in vial form | Weight loss, OSA in adults with obesity | N/A |
How does Healify Clinic Help?
Healify Clinic provides an affordable, comprehensive online weight loss program designed to help you kickstart your weight loss journey. This program includes a video consultation with a weight loss doctor or specialist of your choice, access to weight loss prescriptions if appropriate, unlimited messaging with your provider and ongoing guidance and support.
Maintaining a healthy weight can offer numerous health benefits such as reducing the risk of heart disease, improving mobility, enhancing sleep quality, and boosting overall well being. Start your weight loss journey today with Healify Clinic keeping in mind that all prescriptions are subject to your healthcare provider’s discretion.






